264 related articles for article (PubMed ID: 29423705)
1. Chemotherapeutic Agents and the Risk of Ischemia and Arterial Thrombosis.
Hassan SA; Palaskas N; Kim P; Iliescu C; Lopez-Mattei J; Mouhayar E; Mougdil R; Thompson K; Banchs J; Yusuf SW
Curr Atheroscler Rep; 2018 Feb; 20(2):10. PubMed ID: 29423705
[TBL] [Abstract][Full Text] [Related]
2. Vascular Complications of Cancer Chemotherapy.
Cameron AC; Touyz RM; Lang NN
Can J Cardiol; 2016 Jul; 32(7):852-62. PubMed ID: 26968393
[TBL] [Abstract][Full Text] [Related]
3. [Vascular Complications Of Cancer Chemotherapy].
Belenkov YN; Privalova EV; Kozhevnikova MV; Kirichenko YY
Kardiologiia; 2018 Sep; 58(Suppl 9):4-9. PubMed ID: 30312566
[TBL] [Abstract][Full Text] [Related]
4. Vascular complications of selected cancer therapies.
Daher IN; Yeh ET
Nat Clin Pract Cardiovasc Med; 2008 Dec; 5(12):797-805. PubMed ID: 18852710
[TBL] [Abstract][Full Text] [Related]
5. Arterial Thrombotic Complications of Tyrosine Kinase Inhibitors.
Wu MD; Moslehi JJ; Lindner JR
Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):3-10. PubMed ID: 33275447
[TBL] [Abstract][Full Text] [Related]
6. Cancer drugs and the heart: importance and management.
Suter TM; Ewer MS
Eur Heart J; 2013 Apr; 34(15):1102-11. PubMed ID: 22789916
[TBL] [Abstract][Full Text] [Related]
7. Management of cardiac toxicity in patients receiving vascular endothelial growth factor signaling pathway inhibitors.
Steingart RM; Bakris GL; Chen HX; Chen MH; Force T; Ivy SP; Leier CV; Liu G; Lenihan D; Lindenfeld J; Maitland ML; Remick SC; Tang WH
Am Heart J; 2012 Feb; 163(2):156-63. PubMed ID: 22305831
[TBL] [Abstract][Full Text] [Related]
8. Cancer Therapy-Associated Thrombosis.
Grover SP; Hisada YM; Kasthuri RS; Reeves BN; Mackman N
Arterioscler Thromb Vasc Biol; 2021 Apr; 41(4):1291-1305. PubMed ID: 33567864
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular toxic effects of antitumor agents: Pathogenetic mechanisms.
Pantazi D; Tselepis AD
Thromb Res; 2022 May; 213 Suppl 1():S95-S102. PubMed ID: 36210569
[TBL] [Abstract][Full Text] [Related]
10. Cardiotoxicity of systemic agents used in breast cancer.
Ades F; Zardavas D; Pinto AC; Criscitiello C; Aftimos P; de Azambuja E
Breast; 2014 Aug; 23(4):317-28. PubMed ID: 24794210
[TBL] [Abstract][Full Text] [Related]
11. Vascular Toxicities of Cancer Therapies: The Old and the New--An Evolving Avenue.
Herrmann J; Yang EH; Iliescu CA; Cilingiroglu M; Charitakis K; Hakeem A; Toutouzas K; Leesar MA; Grines CL; Marmagkiolis K
Circulation; 2016 Mar; 133(13):1272-89. PubMed ID: 27022039
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular effects of systemic cancer treatment.
Senkus E; Jassem J
Cancer Treat Rev; 2011 Jun; 37(4):300-11. PubMed ID: 21126826
[TBL] [Abstract][Full Text] [Related]
13. [Pathophysiology of chemotherapy-associated thrombosis].
Lechner D; Weltermann A
Hamostaseologie; 2009 Jan; 29(1):112-20. PubMed ID: 19151860
[TBL] [Abstract][Full Text] [Related]
14. Thrombotic and bleeding complications associated with chemotherapy.
McMahon BJ; Kwaan HC
Semin Thromb Hemost; 2012 Nov; 38(8):808-17. PubMed ID: 23055392
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular oncology: exploring the effects of targeted cancer therapies on atherosclerosis.
Seijkens TTP; Lutgens E
Curr Opin Lipidol; 2018 Oct; 29(5):381-388. PubMed ID: 30074493
[TBL] [Abstract][Full Text] [Related]
16. Vascular toxicity associated with antineoplastic agents.
Doll DC; Yarbro JW
Semin Oncol; 1992 Oct; 19(5):580-96. PubMed ID: 1411655
[TBL] [Abstract][Full Text] [Related]
17. Thrombosis associated with angiogenesis inhibitors.
Elice F; Rodeghiero F; Falanga A; Rickles FR
Best Pract Res Clin Haematol; 2009 Mar; 22(1):115-28. PubMed ID: 19285278
[TBL] [Abstract][Full Text] [Related]
18. Aortic wall stiffness as a side-effect of anti-cancer medication.
Solomou E; Aznaouridis K; Masoura C; Cutajar I; Toutouzas K; Vlachopoulos C; Tousoulis D
Expert Rev Cardiovasc Ther; 2019 Nov; 17(11):791-799. PubMed ID: 31715108
[No Abstract] [Full Text] [Related]
19. Cardiotoxic effects of chemotherapy: A review of both cytotoxic and molecular targeted oncology therapies and their effect on the cardiovascular system.
Babiker HM; McBride A; Newton M; Boehmer LM; Drucker AG; Gowan M; Cassagnol M; Camenisch TD; Anwer F; Hollands JM
Crit Rev Oncol Hematol; 2018 Jun; 126():186-200. PubMed ID: 29759560
[TBL] [Abstract][Full Text] [Related]
20. Approach to chemotherapy-associated thrombosis.
Oppelt P; Betbadal A; Nayak L
Vasc Med; 2015 Apr; 20(2):153-61. PubMed ID: 25832603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]